anticarcinogenic [qlco]    
IMPACT [gngm]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
LARGE [qnco]    
Scale, NOS [medd]    
long-term study [resa]    
Single [popg]    
Centre [spco]    
anticarcinogenic [qlco]    
Capacity [qnco]    
Assessed [acty]    
-- Japanese [popg]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
en masse [topp]    
Patients [podg]    
Methods [inpr]    
Hepatocarcinogenesis [neop]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
RECEIVED [qlco]    
therapy [ftcn]    
Hepatocarcinogenesis [neop]    
In [qnco]    
Treated [ftcn]    
untreated [fndg]    
Patients [podg]    
4 - 6 [qnco]    
End [spco]    
5th [qnco]    
YEAR [tmco]    
YEAR [tmco]    
YEAR [tmco]    
Completion [qlco]    
therapy [ftcn]    
Treated [ftcn]    
Decreased [qnco]    
Hazard Ratio [qnco]    
Carcinogenesis [neop]    
Adjustments [inbe]    
Including [ftcn]    
Fibrosis stage [clna]    
Gender [orga]    
Platelet Count [lbpr]    
Patients [podg]    
Treated [ftcn]    
Persistent [tmco]    
Loss [qnco]    
Additional [ftcn]    
Gained [qnco]    
NORMAL [qlco]    
Levels [qlco]    
Loss [qnco]    
Long [qlco]    
Completion [qlco]    
Cumulative [qlco]    
Hepatocarcinogenesis [neop]    
Sustained [ftcn]    
Virological [ftcn]    
Biochemical [ftcn]    
End [spco]    
5th [qnco]    
YEAR [tmco]    
1 - 9% [fndg]    
3 6 [fndg]    
YEAR [tmco]    
1 - 9% [fndg]    
YEAR [tmco]    
Hazard Ratio [qnco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Biochemical [ftcn]    
Response [orga]    
Normalization [resa]    
Levels [qlco]    
therapy [ftcn]    
Loss [qnco]    
SERUM [bdsu]    
Decreased [qnco]    
Hepatocarcinogenesis [neop]    
Decreased [qnco]    
Hepatocarcinogenesis [neop]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
Whole [qnco]    
JAPAN [geoa]    
Fail [ftcn]    
Clear [fndg]    
SERUM [bdsu]    
Copyright [inpr]    
AG [geoa]    
Basel [hcro]    
